GNH USA

Europe — EMA

Lasitone

GNH USA supplies Lasitone (Furosemide/Spironolactone), a diuretic for edema and hypertension, including heart failure and liver cirrhosis. Request a quote.

Furosemide, Spironolactone

Request sourcing

1
Pack/s

What is Furosemide, Spironolactone?

Furosemide and Spironolactone, the active ingredients in Lasitone, are diuretics presented as oral tablets for oral use. They are prescribed to manage fluid overload and hypertension in adults. GNH USA supplies Lasitone as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Furosemide, Spironolactone used for?

Lasitone, a combination diuretic, is employed to control fluid retention and high blood pressure. - Edema associated with heart failure: reduces excess fluid and eases breathing difficulty. - Edema due to liver cirrhosis: promotes diuresis to lower abdominal swelling. - Edema due to renal disease: helps eliminate retained sodium and water. - Hypertension: lowers blood pressure by increasing urinary sodium excretion.

What are the side effects of Furosemide, Spironolactone?

Lasitone may cause a range of adverse reactions, some of which are frequent while others are uncommon but serious. Common Side Effects: - Increased urination: frequent or urgent need to void. - Electrolyte disturbances: low potassium, sodium, or magnesium levels. - Dizziness or light‑headedness: especially when standing. - Headache: mild to moderate intensity. - Gastrointestinal upset: nausea, vomiting, or abdominal cramps. Serious or Rare Side Effects: - Severe dehydration or hypotension: can lead to fainting. - Hyperkalemia: excessive potassium accumulation, particularly with spironolactone. - Renal impairment: worsening kidney function in susceptible patients. - Allergic reactions: rash, itching, or swelling of the face and throat.

What precautions apply to Furosemide, Spironolactone?

Before prescribing Lasitone, clinicians should evaluate patient-specific factors and monitor therapy closely. - Electrolyte monitoring: check serum potassium, sodium, and magnesium regularly. - Renal function: assess creatinine and eGFR before and during treatment. - Hepatic impairment: use with caution in patients with liver disease. - Pregnancy and lactation: safety not established; avoid unless benefit outweighs risk. - Concomitant drugs: review for interactions that affect potassium or renal function. Store at ambient temperature: keep below 25°C in the original container, protect from moisture and light.

What does Furosemide, Spironolactone interact with?

Lasitone can interact with several medicines, requiring either avoidance or close monitoring. Major Interactions (Avoid): - NSAIDs: may blunt diuretic efficacy and increase renal risk. - ACE inhibitors or ARBs: can precipitate severe hypotension and hyperkalemia. - Lithium: reduced clearance may cause toxicity. - Other potassium‑sparing diuretics: risk of dangerous hyperkalemia. - Aminoglycoside antibiotics: heightened nephrotoxicity potential. Moderate Interactions (Monitor Closely): - Antihypertensives: additive blood‑pressure lowering effect. - Digoxin: altered serum levels due to electrolyte shifts. - Corticosteroids: may enhance sodium retention counteracting the diuretic.

Frequently asked questions

What conditions is Lasitone used to treat?+
Lasitone is indicated for the management of edema associated with heart failure, liver cirrhosis, and renal disease, as well as for the treatment of hypertension. It helps reduce fluid accumulation and lower blood pressure by promoting the excretion of excess sodium and water.
How does the combination of furosemide and spironolactone work in Lasitone?+
Furosemide acts on the loop of Henle to block the Na+/K+/2Cl‑ cotransporter, producing a strong diuretic effect. Spironolactone blocks aldosterone receptors in the distal nephron, reducing sodium reabsorption while conserving potassium. Together they provide effective fluid removal with a balanced electrolyte profile.
What is the usual dose of Lasitone?+
The dosage of Lasitone is individualized by the prescribing clinician based on the patient’s condition, renal function, and response to therapy. The prescriber determines the appropriate strength, frequency, and duration of treatment.
Is Lasitone safe to use during pregnancy or breastfeeding?+
Safety of Lasitone in pregnancy and lactation has not been established. It should only be used if the potential benefit justifies the possible risk to the fetus or infant, and this decision must be made by a qualified healthcare professional.
How do I order Lasitone from GNH USA?+
To order Lasitone, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.
How does Lasitone compare with other diuretic therapies?+
Lasitone combines a loop diuretic (furosemide) with a potassium‑sparing agent (spironolactone), offering stronger fluid removal than a single agent while mitigating potassium loss. This dual action can be more effective than using either class alone, especially in patients with resistant edema or hypertension.
What are the storage requirements for Lasitone?+
Lasitone tablets should be stored at ambient temperature, below 25 °C. Keep them in the original packaging, protect from moisture and direct light, and ensure the container is tightly closed to maintain product stability.
How is Lasitone administered?+
Lasitone is taken orally, usually with a full glass of water. The tablet should be swallowed whole and not chewed or crushed, unless otherwise directed by a healthcare professional.
What are the most serious risks associated with Lasitone?+
Serious risks include severe dehydration, hypotension, electrolyte imbalances such as hyperkalemia or hyponatremia, and worsening renal function. Patients should be monitored for signs of these conditions, especially during the initial phases of therapy.
Who should not use Lasitone?+
Lasitone is contraindicated in patients with anuria, severe renal impairment, known hypersensitivity to furosemide or spironolactone, and in those with hyperkalemia. Caution is also advised for individuals with significant hepatic disease or uncontrolled electrolyte disturbances.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Furosemide, Spironolactone
Route
Oral Use
Manufacturer
Sanofi S.R.L.
Origin
EU

Related products